King, Philip D.

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

Brentjens, R. J., Latouche, J.-B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D., Larson, S., Weiss, M., Rivière, I., et al. (2003) · Nature Medicine

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 669

MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine

Angiogenesis and VEGF in CancerMicroRNA in disease regulation

Cited by 517

Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling

Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 74

RASA1 regulates the function of lymphatic vessel valves in mice

Lapinski, P. E., Lubeck, B. A., Chen, D., Doosti, A., Zawieja, S. D., Davis, M. J., & King, P. D. (2017) · Journal of Clinical Investigation

Lymphatic System and DiseasesVascular Malformations and Hemangiomas

Cited by 71

Transport and Immune Functions of the Lymphatic System.

Davis, M. J., Zawieja, S. D., & King, P. D. (2025) · Annual Review of Physiology

Lymphatic System and DiseasesLymphatic Disorders and Treatments

Cited by 42

The C2 domain augments Ras GTPase-activating protein catalytic activity

Paul, M. E., Chen, D., Vish, K. J., Lartey, N. L., Hughes, E., Freeman, Z. T., Saunders, T. L., Stiegler, A. L., King, P. D., & Boggon, T. J. (2025) · Proceedings of the National Academy of Sciences

Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases

Cited by 7